These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11679881)

  • 1. Management of gamma-hydroxybutyrate withdrawal.
    Sharma AN; Lombardi MH; Illuzzi FA; Nelson LS
    Ann Emerg Med; 2001 Nov; 38(5):605-7. PubMed ID: 11679881
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal.
    Mullins ME; Fitzmaurice SC
    J Emerg Med; 2001 May; 20(4):418-20. PubMed ID: 11396429
    [No Abstract]   [Full Text] [Related]  

  • 3. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven days of gamma-hydroxybutyrate (GHB) use produces severe withdrawal.
    Perez E; Chu J; Bania T
    Ann Emerg Med; 2006 Aug; 48(2):219-20. PubMed ID: 16857475
    [No Abstract]   [Full Text] [Related]  

  • 5. gamma-Hydroxybutyrate withdrawal and chloral hydrate.
    Hutto B; Fairchild A; Bright R
    Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-Hydroxybutyrate.
    White CM
    J Clin Pharmacol; 2017 Jan; 57(1):33-39. PubMed ID: 27198055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of gamma-hydroxybutyrate withdrawal].
    Strand NAW; Petersen TS; Nielsen LM; Boegevig S
    Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts].
    Lenzenhuber E; Müller C; Rommelspacher H; Spies C
    Anaesthesist; 1999 Feb; 48(2):89-96. PubMed ID: 10093649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
    Liao PC; Chang HM; Chen LY
    J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of γ-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report.
    Caputo F; Bernardi M; Zoli G
    J Clin Psychopharmacol; 2011 Feb; 31(1):140-1. PubMed ID: 21192167
    [No Abstract]   [Full Text] [Related]  

  • 11. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
    Rosenberg MH; Deerfield LJ; Baruch EM
    Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
    Glasper A; McDonough M; Bearn J
    Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe delirium in withdrawal from chronic gamma-hydroxybutyric acid consumption].
    Proest G; Zschernack T; Stelzig M; Steinacher B
    Nervenarzt; 2009 May; 80(5):607-8. PubMed ID: 19252889
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression Following γ-Hydroxybutyrate Withdrawal: A Case Report.
    Domínguez I; Bruguera P; Balcells-Oliveró M; Batalla A
    J Clin Psychopharmacol; 2015 Oct; 35(5):618-9. PubMed ID: 26284931
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of severe withdrawal from gamma-hydroxybutyrate.
    Chin RL
    Ann Emerg Med; 2001 May; 37(5):551-2. PubMed ID: 11326198
    [No Abstract]   [Full Text] [Related]  

  • 18. Gamma hydroxybutyrate withdrawal in an orthopedic trauma patient.
    Slagel B; Kingstone E; Bhalerao S
    Can J Psychiatry; 2003 Mar; 48(2):131-2. PubMed ID: 12655920
    [No Abstract]   [Full Text] [Related]  

  • 19. [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].
    Veerman SR; Dijkstra HN; Liefting-Kluft I
    Tijdschr Psychiatr; 2010; 52(6):411-6. PubMed ID: 20544599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital.
    Choudhuri D; Cross S; Dargan PI; Wood DM; Ranjith G
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):154-6. PubMed ID: 23485126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.